McDonnell Boehnen Hulbert & Berghoff LLP partner Dr. Kevin E. Noonan is quoted in a June 14, 2012 edition of Law360.com in an article entitled, “Health Care Ruling Could Mean Years Of Delay For Biosimilars.” The articles focuses on what could happen if the U.S. Supreme Court decides to strike down the entire health care law and how such a ruling could delay the debut of biosimilars onto the U.S. market for months or even years. View the article